RAD9A and cancer: To understand the role of hypermethylation of RAD9A in cancer and oncogenic transformation, we further analyzed BT-549 (breast cancer), MCF7 (breast cancer), EFO-21 (ovary), T47D (breast cancer), and FaDu (squamous cell carcinoma) cell lines.